Cholinergic degeneration in prodromal and early Parkinson’s disease: a link to present and future disease states - Top-Institutions - MDSpire

Cholinergic degeneration in prodromal and early Parkinson’s disease: a link to present and future disease states

  • By

  • Tamir Eisenstein

  • Karolien Groenewald

  • Ludo van Hillegondsberg

  • Falah Al Hajraf

  • Tanja Zerenner

  • Michael A Lawton

  • Yoav Ben-Shlomo

  • Ludovica Griffanti

  • Michele T Hu

  • Johannes C Klein

  • May 6, 2025

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University College London (UCL) Queen Square Institute of Neurology
    University College London (UCL) Queen Square Institute of Neurology

    London, N/A

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Neuroimaging

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Neuroimaging

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Neurodegenerative Disease Research

  • #4

    University of California, San Francisco (UCSF) Memory and Aging Center
    University of California, San Francisco (UCSF) Memory and Aging Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Cognitive Neurology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Neurology
    • Neurodegenerative Disorders
    • Neuroimaging

Original Source(s)

Cholinergic degeneration in prodromal and early Parkinson’s disease: a link to present and future disease states

  • by Tamir Eisenstein, Karolien Groenewald, Ludo van Hillegondsberg, Falah Al Hajraf, Tanja Zerenner, Michael A Lawton, Yoav Ben-Shlomo, Ludovica Griffanti, Michele T Hu, Johannes C Klein

  • May 6, 2025

Related Content

Differential Analysis of Homocysteine and Uric Acid Levels in Patients with Cognitive Impairment Due to Parkinson’s Disease and Post-Stroke Conditions

ARPA-H Launches New Program to Deliver Rigorous, Gold-Standard Research Faster

Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study